Psychiatry Excellence Profile picture
Apr 2 9 tweets 3 min read Read on X
Addiction is not just about reward.

It reflects predictable dysfunction across brain systems governing behaviour, learning, and control.

Here are 5 core neurobiological processes underlying addiction and relapse: 🧵👇

(Click through to see all 5) Image
1/ Reward & Motivation

Chronic substance use floods the brain with dopamine, eventually downregulating D2 receptors.

This structurally shifts the brain from "liking" the drug (hedonic pleasure) to intensely "wanting" it (incentive salience).

The biological urge to use becomes overpowering, even when the substance ceases to provide actual pleasure.

Educating patients that the craving they feel is a structural reflex, not a reflection of character, relieves guilt and contextualises relapse.Image
2/ Conditioning

When a substance repeatedly spikes dopamine, the amygdala and hippocampus form pathological associative memories linking the high to neutral environmental cues (places, paraphernalia).

This Pavlovian learning rewires the brain to anticipate the substance, meaning a single stimulus can provoke involuntary cravings years into recovery.

It helps explain why conditioned cues can contribute to craving and relapse risk even after prolonged abstinence.Image
3/ Self-Regulation Impairment

Chronic use physically impairs the prefrontal cortex, dismantling the brain’s "brake" system.

This deficit reduces impulse inhibition, shifting behaviour to rigid, automatic habits mediated by the dorsal striatum.

Interventions must actively aim to strengthen executive function and disrupt automatic routines to help rebuild the patient's compromised cognitive control.Image
4/ Negative Mood and Stress Reactivity

Late-stage addiction relies on negative reinforcement.

The extended amygdala activates stress pathways, inducing severe psychological agony known as allostasis.

Patients no longer use to chase a high; they use compulsively to escape this withdrawal-induced dysphoria.

Recognising this shift highlights that treatment must prioritise the physiological stabilisation of the stress axis, rather than just reward blockade.Image
5/ Interoceptive Awareness

Addiction disrupts the insular cortex, which governs how we perceive internal bodily states.

This sensory dysregulation “causes” patients to misinterpret normal physiological signals, like mild anxiety or a racing heart, as severe withdrawal or an intense craving.

Incorporating mindfulness and biofeedback in treatment helps patients accurately reinterpret these somatic signals, preventing normal stress from leading to a relapse.
5 Core Neurobiological Processes Underlying Addiction and Relapse

1. Reward & Motivation: D2 downregulation shifts pleasure to intense “wanting”; psychoeducation reframes cravings and reduces guilt.

2. Conditioning: Learned associations mean cues (e.g., people, places, emotions) can trigger relapse even after abstinence.

3. Self-Regulation Impairment: PFC dysfunction weakens impulse control; interventions must rebuild executive function.

Continue...
4. Negative Mood & Stress: Late-stage addiction is associated with negative reinforcement via the extended amygdala (allostasis). Prioritise physiological stabilisation of the stress axis.

5. Interoceptive Awareness: Insular dysregulation misinterprets normal somatic signals as severe cravings. Incorporate biofeedback and mindfulness to help patients accurately reinterpret these cues.
To learn more about addiction and its implications in clinical practice, click the link below and check our course in The Academy.

psychscene.co/419Eg9X

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Psychiatry Excellence

Psychiatry Excellence Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @psycheureka

Apr 1
More than 50% of patients with schizophrenia smoke tobacco. [Fond et al 2017]; [Dickerson et al 2018]; [Oluwoye et al 2019]

Despite heavily substantiated nicotine-induced metabolic and pharmacokinetic risks, this number refuses to drop.

This raises the question: “What does nicotine do that makes this specific patient population so uniquely dependent on it?”

Here’s a neurobiological breakdown of nicotine dependence in schizophrenic patients clinicians should know: 🧵👇Image
The Intrinsic Receptor Deficit

In the general population, chronic smoking leads to an upregulation of α4β2 nicotinic receptors.

In schizophrenia, this compensatory upregulation is impaired.

This suggests an intrinsic defect in the nicotinic receptor system. 

Theoretically, for schizophrenia patients, smoking is an attempt to achieve receptor saturation to overcome this deficit, though it rarely leads to sustained cognitive improvement.Image
Chasing Prefrontal Dopamine

The prefrontal cortex (PFC) is often hypo-active in schizophrenia.

Nicotine attempts to bypass this.

By stimulating receptors on glutamatergic terminals, nicotine:

- Facilitates PFC activity
- Triggers a release of dopamine

This temporarily improves executive function and working memory.
Read 8 tweets
Mar 30
Depression is not a single, uniform brain pattern.

It does not present the same way in every patient.

Sometimes it appears as rumination.
Sometimes as cognitive dysfunction.
Sometimes as emotional over-reactivity.

So how do we make sense of what’s happening beneath the surface? There is a structured way to approach this.

Here is a clinical breakdown of the Triple Network Model, a framework for understanding functional brain changes in depression 🧵👇Image
The Triple Network Model frames depression as dysregulation within and between three major functional brain systems.

Rather than locating the disorder in one isolated region, it conceptualises depression as a disturbance in large-scale network organisation.

This gives clinicians a more structured way to think about why depressive presentations can differ so markedly.
1/ Default Mode Network (DMN)

In depression, dysfunction of the DMN is linked to altered self-referential processing.

The DMN is primarily active at rest and is involved in emotional regulation, social cognition, future-oriented thinking, autobiographical memory, and self-focused mental activity.

When dysregulated, external information may be processed through a more self-referential lens.

Dysfunction in parietal DMN components is also linked to rumination.Image
Read 8 tweets
Mar 27
PTSD treatment is not just about reducing symptoms.

The other half of the clinical equation is about interrupting the mechanisms that make the brain increasingly reactive over time.

To do so, there are 2 clinical PTSD concepts clinicians must take into full consideration in treatment planning: 🧵👇Image
PTSD develops through a combination of psychological and biological mechanisms.

This dual foundation also means that effective treatment must address both sides of the disorder, often integrating psychotherapy with pharmacotherapy.

This is where the following concepts come in, illustrating exactly what is happening in the dysregulated brain, helping clinicians align their intervention strategies with the underlying pathology.Image
1/ The Concept of Kindling 

Following trauma, the brain’s stress systems become dysregulated, creating heightened fear conditioning where even neutral stimuli become associated with threat.

Kindling is the process where increasingly lower-severity stimuli begin to elicit significant negative emotional or physiological responses over time.

This explains why patients often react strongly to seemingly minor cues.Image
Read 8 tweets
Mar 25
For decades, Major Depressive Disorder (MDD) has been clinically framed primarily through mood symptoms.

However, recent clinical studies have described a potential emerging biotype of MDD whose core pathology leans more towards cognition than just mood symptoms.

Here are 5 key clinical insights clinicians need to know about this emerging cognitive MDD biotype:🧵👇Image
Cognition has long been recognised as part of MDD, with impairments in areas such as attention, working memory, and processing speed already linked to poorer function and poorer treatment outcomes.

Even so, MDD remained primarily organised around mood symptoms, with cognitive dysfunction often treated as secondary rather than defining.

This emerging cognitive biotype shifts that framing by suggesting that, in some patients, cognition may be more central to the pathology itself.
1/ Impairment in Cognitive Control Domains

A key feature of the cognitive MDD biotype is impairment in cognitive control-related domains.

The most consistently affected functions are executive function and response inhibition.

In clinical terms, this places the subtype within higher-order cognitive processes involved in organising behaviour, regulating responses, and maintaining goal-directed performance.Image
Read 10 tweets
Mar 22
Addiction vulnerability is heritable.

While often framed as a brain reward-system dysfunction, clinical studies suggest that genetic factors are estimated to account for around 40-60% of addiction risk, with inherited vulnerability contributing to susceptibility. [Volkow et al., 2019]

This raises the next question: How does inherited risk translate into biological vulnerability, and what does that mean in clinical practice?🧵👇Image
The Polygenic Architecture of Vulnerability

What is inherited is not addiction itself, but vulnerability.

This vulnerability is polygenic: multiple variants, especially in dopamine and glutamate systems, increase susceptibility.

In effect, what is inherited may be a reward-system profile prone to dysregulated reinforcement.

This may explain why some individuals show greater neurobiological vulnerability even before substance exposure.Image
Altered Dopaminergic Regulation

Heritable vulnerability to addiction may be associated with alterations in dopaminergic regulation.

When dopamine balance is harder to maintain, the brain’s reward pathways may respond less efficiently to ordinary rewarding stimuli.

In that sense, inherited risk may begin at the level of reward regulation, not only at the point of substance exposure.Image
Read 9 tweets
Mar 20
Around 70% of adults globally experience at least one traumatic event, with a proportion of individuals subsequently developing PTSD. [Benjet et al., 2016]

However, standard clinical approaches to PTSD remain largely binary: patients either meet the symptom checklist, or they don't. 

But what if underlying pathological processes begin long before the DSM checklist is met? 

To bridge this gap, here’s a 5-stage clinical staging approach to PTSD clinicians can apply in practice:🧵👇Image
Stage 0: Trauma Exposed & Asymptomatic

Before clinical diagnosis, neurobiological changes associated with trauma exposure may begin to emerge. 

Trauma exposure has been associated with alterations in glucocorticoid receptor sensitivity, circadian regulation, and amygdala reactivity. 

Clinically, individuals may exhibit transient attention bias and deficits in extinction learning.

This is the "watch-and-wait" phase, where early resilience strategies may be highly beneficial.Image
Stage 1A: Undifferentiated Mild Anxiety & Distress

In this stage, early signs of dysregulation emerge.

This phase is associated with inflammatory cytokine activation and decreasing response inhibition in frontal cognitive systems.

Patients do not yet meet PTSD criteria, but clinically experience a heightened basic stress level, mild attention or memory difficulties, and early disruption of normal sleeping patterns.
Read 9 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(